Management of Left M1 Occlusion After Thrombectomy

Immediate Post-Thrombectomy Care

• The American Heart Association recommends assessing recanalization success using the Thrombolysis in Cerebral Infarction (TICI) scale, with TICI 2b/3 being the technical goal to maximize probability of good functional outcome 1
• The American College of Cardiology suggests maintaining appropriate blood pressure control, aiming for systolic blood pressure of 130-150 mmHg to prevent hemorrhagic complications 2

Antithrombotic Management

• The American College of Cardiology recommends initiating anticoagulation therapy after ruling out hemorrhagic transformation for cardioembolic sources 3
• The American Heart Association suggests considering antiplatelet therapy, typically dual antiplatelet therapy initially followed by long-term single antiplatelet therapy for atherosclerotic disease 4

Management of Underlying Carotid Disease

• The American Heart Association recommends considering stenting of the underlying stenosis during the thrombectomy procedure for patients with tandem lesions, though this approach was used in only 40% of such cases in clinical trials 4

Follow-up Care

• The American College of Cardiology recommends regular neurological assessments to monitor for clinical improvement or deterioration 3
• The American Heart Association suggests providing secondary stroke prevention measures based on identified etiology 4

Common Pitfalls to Avoid

• The American College of Cardiology warns against failing to identify and treat the underlying cause, leading to recurrent stroke 4
• The American Heart Association advises against initiating anticoagulation too early in patients with large infarcts, increasing hemorrhagic transformation risk 3
• The American College of Cardiology recommends avoiding inadequate blood pressure control, which can lead to hemorrhagic complications 2

Management of Left M1 Occlusion After Thrombectomy

Antithrombotic Management Based on Etiology

• For patients with tandem lesions (cervical carotid stenosis/occlusion with intracranial occlusion), the American Heart Association recommends considering stenting of the underlying stenosis 5

Management of Complications

• For thromboembolic complications occurring during or shortly after the procedure, the American Association of Neurological Surgeons suggests considering intra-arterial thrombolysis with recombinant tissue plasminogen activator (t-PA) or urokinase, and abciximab administration for high-risk patients 6